Pulmonology

The drug has potential to be best-in-class treatment option for children aged 6-11 years with uncontrolled moderate-to-severe asthma.

Two-thirds of all excess deaths this year have been directly driven by the pandemic, according to findings.

An expert offers 5 tips to physicians and patients on best practices for managing symptoms related to allergic asthma.

The Digihaler is a digital inhaler aimed at improving inhaler techniques.

Dr. Fauci gives perspective on the future presence of the virus, improving US pandemic preparedness, and the theological divisions which have plagued national response.

Researchers suggest avoiding cow’s milk formula for newborns in the first 3 days of life.

What the potential of monoclonal antibodies may be, and what's currently understood about serologic antibodies.

This edition from the 10 Year Plan features perspective from leadership at AAAAI and ACAAI, as well as survey results from allergists and pulmonologists.

An expert discusses how allergies can make it easier for viruses to enter the body as well as the association between asthma and COVID-19 severity.

Fauci shares his thoughts on leading COVID-19 vaccines, SARS-CoV-2 transmission, antibody research, and where the US went wrong in pandemic response.

There was a high proportion of RSV-associated acute lower respiratory infections hospitalizations in infants younger than 1 in all countries.

Low annual donor use and high mortality rates could be correlatively improved with greater embrace of opportunities.

The trial did not reach full enrollment.

About 2/3 of children with asthma had been exposed to opioids prior to birth, according to a new retrospective study.

HRV-induced cytokine responses were reduced in patients with severe asthma.

Pulmonary conditions like asthma could often lead to the development of chronic cough.

Despite not being able to attend conferences live, there are some advantages to a virtual conference.

The molecular mechanisms of steroid resistance suggest the P13K/Akt signaling pathway and the MAPK signaling pathway are involved.

New cohort analysis shows an over-reliance on therapy designed as an add-on for asthma control.

Twelve-year data shows patients without control of their asthma could suffer lung failure quickly if they aren't consistent in maintenance therapy.

Asthma patients have not had higher rates of negative outcomes from COVID-19 than other individuals.

The biologic drug is set to be used as a combination therapy for asthma.

In a study presented at ERS, researchers IOS could be used for assessment level of asthma control in both adult and pediatric patients.

New data shows nearly 40% of chronic lung disease patients from a Portuguese hospital died within 5 years of initiating respiratory rehabilitation.

Patients saw improvement in symptom perception, activity limitation, emotional function, and environmental stimuli.